Literature DB >> 21990411

More is not necessarily better when treating Hodgkin's lymphoma.

Joseph M Connors.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990411     DOI: 10.1200/JCO.2011.37.1377

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Long-term structured follow-up is essential after curative cancer treatment.

Authors:  Ulrich Keilholz; Antonio Pezzutto; Volker Budach; Angelika Eggert
Journal:  Dtsch Arztebl Int       Date:  2014-01-06       Impact factor: 5.594

2.  Brentuximab vedotin treatment for primary refractory hodgkin lymphoma.

Authors:  Hung-Bo Wu; Shyh-An Yeh; Huei-Yung Chen
Journal:  Case Rep Hematol       Date:  2013-10-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.